HCPLive Network

Alzheimer's Disease

Alzheimer ’s disease (AD) has a long preclinical phase in which pathology develops years or decades before clinical symptoms. In study in JAMA Psychiatry, Robert Pietrzak, PhD, MPH and colleagues report that depression, anxiety and cognitive decline are associated with presence of Amyloidβ but that patients will benefit if their depression and anxiety are treated.
Finding brain beta amyloid is usefull in assessing Alzheimer's Disease. In a report in JAMA Neurology, Craig Curtis, MD, and colleagues report on a multicenter PET imaging study on terminally ill dementia patients using flutemetamol injections tagged with radioactive fluorine 18. In cases where autopsy was later possible, the team assessed how accurate the tests had been in diagnosing Alzheimer's.
Four factors have been identified that affect quality of life from the perspective of people with dementia. The findings were published in the January issue of the Journal of the American Geriatrics Society.
MRI scans are a viable testing option for early indicators of Alzheimer’s disease, according to research from Northwestern University.
Regularly speaking 2 or more languages can delay the onset and diagnosis of Alzheimer’s disease by 4 years, according to research from Belgium.
For nursing home residents with dementia taking statins, most continue statins with the progression to advanced dementia, according to research published in the November issue of the Journal of the American Geriatrics Society.
Alzheimer's Disease Upcoming Events
Mesa, AZ
February 28, 2014
Keystone, CO
March 2-7, 2014
Charleston, SC
March 14-16, 2014
Copenhagen, Denmark
July 12-17, 2014
Taos, New Mexico
January 25-30, 2015
Nice, France
March 18-22, 2015
Perth, Australia
April 15-18, 2015
Seattle, WA
April 16, 2015
Washington, DC
July 18-23, 2015
Alzheimer's Disease Latest News
Alzheimer's Disease Clinical Trials
Alzheimer's Disease Resources